Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 151

1.

Sclerostin and its association with physical activity, age, gender, body composition, and bone mineral content in healthy adults.

Amrein K, Amrein S, Drexler C, Dimai HP, Dobnig H, Pfeifer K, Tomaschitz A, Pieber TR, Fahrleitner-Pammer A.

J Clin Endocrinol Metab. 2012 Jan;97(1):148-54. doi: 10.1210/jc.2011-2152. Epub 2011 Oct 12.

PMID:
21994959
[PubMed - indexed for MEDLINE]
2.

Serum sclerostin levels negatively correlate with parathyroid hormone levels and free estrogen index in postmenopausal women.

Mirza FS, Padhi ID, Raisz LG, Lorenzo JA.

J Clin Endocrinol Metab. 2010 Apr;95(4):1991-7. doi: 10.1210/jc.2009-2283. Epub 2010 Feb 15.

PMID:
20156921
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Serum sclerostin levels are decreased in adult patients with different types of osteogenesis imperfecta.

Kocijan R, Muschitz C, Fahrleitner-Pammer A, Amrein K, Pietschmann P, Haschka J, Dinu S, Kapiotis S, Resch H.

J Clin Endocrinol Metab. 2014 Feb;99(2):E311-9. doi: 10.1210/jc.2013-2244. Epub 2013 Nov 7.

PMID:
24203063
[PubMed - indexed for MEDLINE]
4.

Serum sclerostin levels were positively correlated with fat mass and bone mineral density in central south Chinese postmenopausal women.

Sheng Z, Tong D, Ou Y, Zhang H, Zhang Z, Li S, Zhou J, Zhang J, Liao E.

Clin Endocrinol (Oxf). 2012 Jun;76(6):797-801. doi: 10.1111/j.1365-2265.2011.04315.x.

PMID:
22151063
[PubMed - indexed for MEDLINE]
5.

Association of circulating sclerostin with bone mineral mass, microstructure, and turnover biochemical markers in healthy elderly men and women.

Durosier C, van Lierop A, Ferrari S, Chevalley T, Papapoulos S, Rizzoli R.

J Clin Endocrinol Metab. 2013 Sep;98(9):3873-83. doi: 10.1210/jc.2013-2113. Epub 2013 Jul 17.

PMID:
23864703
[PubMed - indexed for MEDLINE]
6.

Association of circulating sclerostin levels with fat mass and metabolic disease--related markers in Japanese postmenopausal women.

Urano T, Shiraki M, Ouchi Y, Inoue S.

J Clin Endocrinol Metab. 2012 Aug;97(8):E1473-7. doi: 10.1210/jc.2012-1218. Epub 2012 May 25.

PMID:
22639287
[PubMed - indexed for MEDLINE]
7.

Sclerostin levels associated with inhibition of the Wnt/β-catenin signaling and reduced bone turnover in type 2 diabetes mellitus.

Gaudio A, Privitera F, Battaglia K, Torrisi V, Sidoti MH, Pulvirenti I, Canzonieri E, Tringali G, Fiore CE.

J Clin Endocrinol Metab. 2012 Oct;97(10):3744-50. doi: 10.1210/jc.2012-1901. Epub 2012 Aug 1.

PMID:
22855334
[PubMed - indexed for MEDLINE]
8.

Gender differences in sclerostin and clinical characteristics in type 1 diabetes mellitus.

Catalano A, Pintaudi B, Morabito N, Di Vieste G, Giunta L, Bruno ML, Cucinotta D, Lasco A, Di Benedetto A.

Eur J Endocrinol. 2014 Sep;171(3):293-300. doi: 10.1530/EJE-14-0106. Epub 2014 Jun 2.

PMID:
24891138
[PubMed - indexed for MEDLINE]
9.

Sclerostin is positively associated with bone mineral density in men and women and negatively associated with carotid calcified atherosclerotic plaque in men from the African American-Diabetes Heart Study.

Register TC, Hruska KA, Divers J, Bowden DW, Palmer ND, Carr JJ, Wagenknecht LE, Hightower RC, Xu J, Smith SC, Dietzen DJ, Langefeld CD, Freedman BI.

J Clin Endocrinol Metab. 2014 Jan;99(1):315-21. doi: 10.1210/jc.2013-3168. Epub 2013 Dec 20.

PMID:
24178795
[PubMed - indexed for MEDLINE]
10.

Physical activity in relation to serum sclerostin, insulin-like growth factor-1, and bone turnover markers in healthy premenopausal women: a cross-sectional and a longitudinal study.

Ardawi MS, Rouzi AA, Qari MH.

J Clin Endocrinol Metab. 2012 Oct;97(10):3691-9. doi: 10.1210/jc.2011-3361. Epub 2012 Aug 3.

PMID:
22865898
[PubMed - indexed for MEDLINE]
11.

Relation of age, gender, and bone mass to circulating sclerostin levels in women and men.

Mödder UI, Hoey KA, Amin S, McCready LK, Achenbach SJ, Riggs BL, Melton LJ 3rd, Khosla S.

J Bone Miner Res. 2011 Feb;26(2):373-9. doi: 10.1002/jbmr.217.

PMID:
20721932
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Circulating sclerostin in disorders of parathyroid gland function.

Costa AG, Cremers S, Rubin MR, McMahon DJ, Sliney J Jr, Lazaretti-Castro M, Silverberg SJ, Bilezikian JP.

J Clin Endocrinol Metab. 2011 Dec;96(12):3804-10. doi: 10.1210/jc.2011-0566. Epub 2011 Sep 21.

PMID:
21937621
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Serum sclerostin levels in healthy men over 50 years of age.

Bhattoa HP, Wamwaki J, Kalina E, Foldesi R, Balogh A, Antal-Szalmas P.

J Bone Miner Metab. 2013 Sep;31(5):579-84. doi: 10.1007/s00774-013-0451-z. Epub 2013 Mar 24.

PMID:
23525828
[PubMed - indexed for MEDLINE]
14.

Serum sclerostin levels positively correlate with lumbar spinal bone mineral density in postmenopausal women--the six-month effect of risedronate and teriparatide.

Polyzos SA, Anastasilakis AD, Bratengeier C, Woloszczuk W, Papatheodorou A, Terpos E.

Osteoporos Int. 2012 Mar;23(3):1171-6. doi: 10.1007/s00198-010-1525-6. Epub 2011 Jan 11.

PMID:
21305266
[PubMed - indexed for MEDLINE]
15.

Role of sclerostin in the bone loss of postmenopausal chinese women with type 2 diabetes.

Zhou YJ, Li A, Song YL, Zhou H, Li Y, Tang YS.

Chin Med Sci J. 2013 Sep;28(3):135-9.

PMID:
24074614
[PubMed - indexed for MEDLINE]
16.

Circulating sclerostin levels and markers of bone turnover in Chinese-American and white women.

Costa AG, Walker MD, Zhang CA, Cremers S, Dworakowski E, McMahon DJ, Liu G, Bilezikian JP.

J Clin Endocrinol Metab. 2013 Dec;98(12):4736-43. doi: 10.1210/jc.2013-2106. Epub 2013 Sep 13.

PMID:
24037879
[PubMed - indexed for MEDLINE]
17.

Serum levels of insulin-like growth factor-I are related to age and not to body composition in healthy women and men.

O'Connor KG, Tobin JD, Harman SM, Plato CC, Roy TA, Sherman SS, Blackman MR.

J Gerontol A Biol Sci Med Sci. 1998 May;53(3):M176-82.

PMID:
9597048
[PubMed - indexed for MEDLINE]
18.

Determinants of serum sclerostin in healthy pre- and postmenopausal women.

Ardawi MS, Al-Kadi HA, Rouzi AA, Qari MH.

J Bone Miner Res. 2011 Dec;26(12):2812-22. doi: 10.1002/jbmr.479.

PMID:
21812027
[PubMed - indexed for MEDLINE]
19.

Serum extracellular secreted antagonists of the canonical Wnt/β-catenin signaling pathway in patients with Cushing's syndrome.

Belaya ZE, Rozhinskaya LY, Melnichenko GA, Solodovnikov AG, Dragunova NV, Iljin AV, Dzeranova LK, Dedov II.

Osteoporos Int. 2013 Aug;24(8):2191-9. doi: 10.1007/s00198-013-2268-y. Epub 2013 Jan 29.

PMID:
23358608
[PubMed - indexed for MEDLINE]
20.

Circulating sclerostin levels and bone turnover in type 1 and type 2 diabetes.

Gennari L, Merlotti D, Valenti R, Ceccarelli E, Ruvio M, Pietrini MG, Capodarca C, Franci MB, Campagna MS, Calabrò A, Cataldo D, Stolakis K, Dotta F, Nuti R.

J Clin Endocrinol Metab. 2012 May;97(5):1737-44. doi: 10.1210/jc.2011-2958. Epub 2012 Mar 7.

PMID:
22399511
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk